000			01885 a2200517 4500
005			20250517074319.0
264		0	_c20170106
008			201701s 0 0 eng d
022			_a2045-2322
024	7		_a10.1038/srep19626 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Zhifei
245	0	0	_aTubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulation. _h[electronic resource]
260			_bScientific reports _cJan 2016
300			_a19626 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylation
650	0	4	_aAnimals
650	0	4	_aBrain Infarction _xdrug therapy
650	0	4	_aCell Death _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aFibroblast Growth Factors _xgenetics
650	0	4	_aGene Expression Regulation
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aHistone Deacetylase Inhibitors _xpharmacology
650	0	4	_aHydroxamic Acids _xpharmacology
650	0	4	_aIndoles _xpharmacology
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNeurites _xmetabolism
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aRats
650	0	4	_aRecovery of Function _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTubulin _xmetabolism
650	0	4	_aUp-Regulation _xdrug effects
700	1		_aLeng, Yan
700	1		_aWang, Junyu
700	1		_aLiao, Hsiao-Mei
700	1		_aBergman, Joel
700	1		_aLeeds, Peter
700	1		_aKozikowski, Alan
700	1		_aChuang, De-Maw
773	0		_tScientific reports _gvol. 6 _gp. 19626
856	4	0	_uhttps://doi.org/10.1038/srep19626 _zAvailable from publisher's website
999			_c25651689 _d25651689